ABOUT    |  NEWS  |  PRODUCTS  |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER  |  PATIENTS

Stock Information

MOLOGEN AG, Berlin

ISIN:

DE0006637200

Securities Identification Number:

663720

SE code:

MGN

Stock exchange:

Frankfurt stock exchange

Market segment:

Prime Standard (Regulated Market)

Subscribed Capital:

EUR 12,459,275

Number of shares:

12,459,275

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

Nov. 21, 2011

MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule

 

 the press release

Nov. 18, 2011

MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board


 the press release

NEWSLETTER

To receive our press releases please

 click here